INTRODUCTION
The aryl hydrocarbon receptor (AhR) is a ligand-activated basic helix-loop-helix (bHLH) transcription factor that regulates the adaptive and toxic responses to a variety of environmental carcinogens, including polyaromatic hydrocarbons (PAH), such as dioxin (Poland and Knutson, 1982) . In the absence of ligand, the AhR resides predominantly in the cytoplasm in a conformation stabilized by chaperone proteins hsp90, XAP2, and p23 (Carver and Bradfield, 1997; Ma and Whitlock, 1997; Meyer and Perdew, 1999) . The current working model for the AhR signaling proposes that ligand binding to AhR facilitates the dissociation of the chaperone proteins and AhR transformation into a form that readily translocates to the nucleus. In the nucleus, AhR dimerizes with the related bHLH Ah receptor nuclear translocator (ARNT) protein (Kazlauskas et al., 2001) , and binding of this heterodimer to DNA recognition motifs designated as xenobiotic-responsive elements (XREs) results in enhanced transcription of the Ah-responsive genes (Jones et al., 1985) , typified by CYP1A1 and CYP1A2 (Gonzalez et al., 1984) .
The protein products of these CYPs are catalytically active in metabolizing, not only many endogenous compounds such as β -estradiol, but also many drugs, dietary components, mutagens, carcinogens and environmental pollutants (Conney, 1982) . Following transcriptional activation, the liganded-AhR undergoes a rapid degradation (Pollenz, 1996; Prokipcak and Okey, 1991; Reick et al., 1994) . Studies have suggested that this ligand-induced down regulation of AhR is proteasome-dependent (Davarinos and Pollenz, 1999) , and that the nuclear export is required for this process (Song and Pollenz, 2002) .
Although forced dissociation of the chaperone proteins, especially hsp90 by geldanamycin, allows for the nuclear translocation of the receptor it is not sufficient for its transactivation (Song and Pollenz, 2002) .
In vitro studies have shown the AhR to be a substrate for the calcium-dependent protease calpain (Poland and Glover, 1988) , which is a family of cytosolic calcium-dependent cysteine proteases. Calpain is involved in regulating many cellular processes including proliferation, differentiation, cell motility and metastasis through regulation of signal transduction and cleavage of many target cellular regulatory proteins (Potter et al., 1998; Wang, 1990) . Of the several calpain isoforms, calpain I (µ- calpain), and calpain II (m-calpain) are ubiquitous enzymes, activated with low and high calcium concentrations, MOL #27474 5 respectively. Since the treatment of cells with PAH can elicit a rapid increase in intracellular calcium (Hanneman et al., 1996; Tannheimer et al., 1997) , we hypothesize that this increase in intracellular calcium could provide the trigger to activate calpain. Here we have studied the involvement of calpain in the transformation process required for the nuclear translocation, transactivation, and subsequent degradation of AhR.
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MATERIALS AND METHODS

Materials:
Calpain inhibitor III (MDL 28170), PD 150606, carbobenzoxyl-L-leucyl-L-leucyl-leucinal (MG-132), epoxomicin, and Ionomycin were purchased from Calbiochem (San Diego, CA). Dioxin (TCDD) was purchased through NCI Chemical Carcinogen Repository-Midwest Research Institute (Kansas City, MO). The calpain substrate BOC-LM-CMAC and Fluo-4-AM were purchased from Molecular Probes (Eugene, OR). Real time PCR kit was purchased from Bio-Rad (Hercules, CA). The rabbit polyclonal anti-AhR antibodies (Poland and Glover, 1990; Pollenz et al., 1994) were a kind gift from Dr. Christopher
Bradfield, University of Wisconsin (Madison, WI). The Sager MT-2 metastatic cell line was derived from a patient with an infiltrating intraductal carcinoma, and was kindly provided by Dr. Vilma Band from
Northwestern University (Chicago, IL).
Cell Culture and stimulation of MT-2 cells
The metastatic 21MT-2 cell line were grown in DFCI-1 medium as described previously (Band et al., 1990) . For experiments, MT-2 cells were seeded in six-well plates at a density of 5 x 10 5 and grown for 24 hrs. Cells were pre-incubated with inhibitors MG-132, epoxomicin or MDL 28170 for 2 hr and maintained during 3 hr TCDD treatment. TCDD, MG-132, MDL 28170, and epoxomicin were solublized in DMSO, with an equivalent volume added to control cells (maximum of 0.1% v/v). 
Intracellular Calcium Measurements
Immunocytochemical Staining and Fluorescence Microscopy
Cells growing on cover slips in 6-well plates were washed in PBS and then fixed by incubation in a (1:1) methanol: acetone solution at 4ºC for 30 min and subsequently air-dried. For staining, cells were rinsed and hydrated with TBST (10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20) and transferred to clean 6 well plates. The cover slips were incubated at room temperature for 1 hr in 4% milk solution in TBST to block nonspecific binding. The cover slips were then incubated at room temperature for 1 hr in 1 µ g/ml anti-AhR polyclonal antibody (BEAR-4) in 2% milk solution in TBST while rocking. Cover slips were then washed three times (15 min each) with TBST. A 1:200 dilution of fluorescein isothiocyanate (FITC) conjugated goat anti-rabbit antibodies in 2% milk with TBST was added to the cover slips in reduced light, and incubated at room temperature for 1 hr. The cover slips were then washed extensively and mounted onto glass slides using mounting solution containing DABCO as an anti-fading agent.
Preparation of Total Cell Lysates and Immunoblotting
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The protein concentration in cell extracts was determined using the BCA kit, per the manufacturer's instructions. Equivalent amounts of protein (10 µg) were separated by Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred for 2 hr at 175V to Polyvinylidene fluoride (PVDF) membranes. The membranes were blocked at room temperature for 1 hr in 4% nonfat milk in TBST with subsequent incubation with BEAR-3 anti-AhR (1 µ g/ml). After brief washing, blots were incubated with the corresponding HRP-coupled anti-rabbit or anti-mouse secondary antibody
(1:20,000) for 1 hr followed by additional washing in TBST and TBS. Reactive protein bands were visualized using enhanced chemiluminescence reagents. Band density was quantified by UVP BioImaging System using LabWorks Image Acquisition Analysis Software (UVP Laboratory products, Upland, CA). Subsequently, blots were probed with actin monoclonal antibodies (1:4000) for normalization of protein loading. The relative levels of AhR protein were then normalized to the level of β -actin to generate normalized values for the relative concentration of AhR in each sample.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Following lysis with Trizol, total RNA was isolated according to manufacturer's protocol. cDNA was prepared from 2 µg of mRNA using random hexamer primers and Moloney murine leukemia virus reverse transcriptase. CYP1A1 PCR amplification was done using forward primer sequence 5'TAG ACA CTG ATC TGG CTG CAG3' and the reverse primer sequence 5'GGG AAG GCT CCA TCA GCA TC3'. House keeping gene glyceraldehyde 3-phosphate dehydrogenase was amplified as an internal control using forward primer 5'ACC ACA GTC CAT GCC ATC AC3' and reverse primer 5'TCC ACC ACC CTG TTG CTG TA3'. PCR products were visualized in agarose gels stained with ethidium bromide, and bands were quantified by densitometric scanning, as described previously (Eltom et al., 1999) . 
Statistical Analysis
The data from different experiments were analyzed using GraphPad Prism Software (San Diego, CA) by one-way analysis of variance ANOVA and Tukey-Kramer multiple comparison tests of values from control versus treated samples
RESULTS
TCDD Mobilizes Calcium in MT-2 cells
Exposure of human T cells and primary human epithelial cells to PAH leads to the mobilization of intracellular calcium. Because this phenomenon was not observed in the MCF-10A mammary epithelial cell line, which have low concentrations of AhR (Tannheimer et al., 1997) (Fig 1) .
Exposure of cells to TCDD Activates Calpain
Calpain is activated by elevated intracellular calcium, resulting in auto-proteolytic cleavage to further enhance its activity (Mathiasen et al., 2002) . To explore whether TCDD-induced changes in intracellular calcium could lead to calpain activation, whole-cell calpain activity assay was preformed in MT-2 cells using the cell-permeable substrate BOC-LM-CMAC. TCDD exposure resulted in a robust increase in calpain activity, comparable to the levels induced by ionomycin, the ionophore that was used as a positive control (Fig. 2) . These data indicate that TCDD could activate calpain. The activation of calpain by TCDD was strongly inhibited by MDL 28170, a potent calpain inhibitor. Fig 2 also shows that MG-132, which has previously been reported to inhibit both proteasomes and calpain (Mathiasen et al., 2002) , mimicked the effect of MDL 28170 on TCDD-induced calpain activity. Epoxomicin, which inhibits proteasomes only (Meng et al., 1999) , had no effect on calpain activity. These results support the conclusion that TCDD is involved in the activation of calpain in MT-2 cells. The data further establish the selectivity of both MG-132 and MDL 28170 in inhibiting calpain, in agreement with published reports (Mathiasen et al., 2002; Potter et al., 1998) .
TCDD-induced nuclear accumulation of AhR is calpain-dependent
To explore whether calpain might be involved in the transformation of AhR leading to its translocation from the cytoplasm into the nucleus, subcellular localization of AhR was analyzed in Hepa- 
Inhibition of Calpain blocks transcriptional activity of AhR
The expression of CYP1A1, a gene that is transcriptionally regulated by AhR, is induced by increases in intracellular calcium, but the mechanism of this induction is poorly defined (Le Ferrec et al., 2002) . Interestingly, the disruption of hsp90-AhR complex facilitates nuclear localization of the AhR yet fails to induce gene expression. Based on the data presented in Fig. 3 , we presume that calpain-mediated also inhibits calpain, inhibited TCDD-induced CYP1A1 gene expression to the same degree, as MDL28170, while epoxomicin, a proteasome inhibitor, had no effect on the TCDD-induced CYP1A1 MOL #27474 12 expression. Therefore, we conclude that inhibition of calpain preferentially reduces the ability of TCDD to induce the expression of CYP1A1.
AhR degradation following TCDD treatment
The data presented thus far demonstrated that TCDD mobilizes calcium, triggering calpain activation, which could transform the AhR into a transcription factor, possibly by limited cleavage of the receptor. Subsequent to enhancing CYP1A1 transcription, AhR is shuttled from the nucleus to the cytoplasm where it is degraded. To assess whether calpain contributes to this degradation, TCDD-induced AhR degradation was analyzed in the presence and absence of calpain inhibitor MDL 28170. Treatment of MT-2 cells with TCDD resulted in greater than 75% reduction in AhR protein levels (Fig 5A) , and pretreatment with MDL 28170 completely blocked this degradation. However, these treatments with ligand and protease inhibitors, although had an effect on the AhR levels, did not have any effect on the levels of ARNT, the AhR partner for transcriptional activation (Fig 5A) .
Recent reports have implicated proteasomes in the degradation of the AhR therefore the proteasome inhibitors MG-132 and epoxomicin were tested. Epoxomicin, a potent and selective proteasome inhibitor, has no cross-activity against non-proteasomal proteases such as calpain (Meng et al., 1999) , while MG-132 interferes equally with both proteasomes and calpain (Davarinos and Pollenz, 1999; Mailhes et al., 2002) . As shown in Fig. 5B , epoxomicin treatment did not protect the receptor from this TCDD-induced down-regulation whereas MDL 28170 effectively protected the AhR from TCDDinduced down-regulation (Fig. 5B) . Unlike epoxomicin, MG-132 inhibited the TCDD-induced degradation of the AhR, to a comparable level of the MDL 28170 (Fig. 5C ). These results demonstrate that the degradation of the AhR is a calpain-dependent process.
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DISCUSSION
PAHs, such as dioxin, elicit a wide range of toxic effects including carcinogenesis. One way that AhR mediates the toxic responses of these chemicals is through its ability to enhance the transcription of CYP1A1 gene in many tissues. The protein product of CYP1A1 catalyzes the bioactivation of these chemicals as well as some endogenous hormones producing reactive metabolites that cause DNA damage and initiate neoplasia. Data presented in this report provide compelling evidence that the Ca 2+ -dependent protease, calpain is a critical player in driving this AhR-mediated process.
For AhR to direct the ligand-induced CYP1A1 transcription it has been established that ligand binding to AhR results in a sequence of events starting with the receptor dissociation from chaperone proteins, such as hsp90 and adoption of conformational changes that allow the AhR to translocate into the nucleus to bind DNA and activate the transcription of CYP1A1 (Whitlock, 1999) . However, the mere dissociation of the hsp90 from the receptor complex, although allowing for AhR nuclear translocation, is not sufficient to induce the receptor transactivation (Song and Pollenz, 2002) . This observation suggests that additional processing of AhR is required following its dissociation from chaperone proteins. Our data clearly implicate calpain in the transformation required for the AhR nuclear translocation and subsequent transactivation. Inhibition of calpain completely blocked the transcription of CYP1A1, indicating that calpain is required for the transformation of AhR into a transcriptional factor. We demonstrate that the trigger for activation of calpain is provided by elevation in intracellular calcium by AhR ligands such as TCDD, which was previously reported in other cell systems.
Interestingly, previous reports have shown that deletion of the P/S/T domain in the carboxyl terminal of AhR leads to an increase in its transcriptional activity (Kumar et al., 2001) . Although calpain prefers Leu or Val as a second residue on the N-terminal side of cleavage site (Wang, 1990) , it also recognizes hydrophilic sequences enriched in Pro, Glu, Asp, Ser, and Thr (or PEST sequences) near cleavage sites (Wang et al., 1989) . Therefore, it is conceivable that activated calpain could cleave the carboxy-terminal P/S/T domain of AhR resulting in its transcription activation. This truncated form of AhR may be recognized by the importin receptors of the nuclear membrane in a ligand-dependent or MOL #27474 14 ligand-independent manner. Intriguingly enough, such a truncated form of AhR (~90 kDa) was recovered from nuclei of TCDD-treated Hepa-1 cells, which was slightly smaller than the cytosolic AhR in these cells (~95 kDa) (Eltom, unpublished data) .
Following transcriptional activation, the liganded-AhR undergoes a rapid degradation leading to a massive depletion (Prokipcak and Okey, 1991) . Some studies have suggested that this process is proteasome-dependent (Davarinos and Pollenz, 1999) . Conversely, studies by Poland and Glover (Poland and Glover, 1988) reported fragments of AhR following increases in calcium concentration, which they attributed to calpain activation. To distinguish the role of the two protease-systems the current study utilized highly selective inhibitors of both calpain and proteasomes, with no overlapping reactivity.
Although the inhibitor MG-132 was used as a proteasome inhibitor to implicate proteasomes in the degradation of the AhR, this report in agreement with others have identified MG-132 as a strong inhibitor of calpain (Mailhes et al., 2002) . Moreover, classical calpain inhibitors, which were used to discredit calpain in the AhR degradation process, have been shown to have less affinity for calpain I and II (Bang et al., 2004) . In our study, MDL 28170, the most potent inhibitor of calpain, demonstrated that calpain is responsible for the transcriptional activation of AhR and subsequent degradation. In addition, MG-132, which exhibits a cross-specificity for calpain and proteasomes, has blocked the TCDD-induced degradation to the same extent as MDL 28170. On the other hand, the proteasome selective inhibitor, epoxomicin failed to prevent TCDD-induced degradation of the receptor. These lines of evidence suggest that calpain is also responsible for the agonist-dependent degradation of AhR.
Thus, the activation of calpain by TCDD contributes to each of the sequential steps of the AhRmediated transcriptional activation of CYP1A1 and the subsequent AhR degradation. We propose a model where TCDD elevates intracellular calcium, triggering calpain activation to both initiate and terminate he AhR signaling. In such model, calcium is the second messenger subsequent to TCDD exposure and calpain is the downstream effector molecule. Transcriptional activation of CYP1A1 by
AhR has been reported in response to agents that do not bind AhR such as caffeine (Goasduff et al., 1996) , oltipraz (Le Ferrec et al., 2002) and omeprazole (Quattrochi and Tukey, 1993) . AhR is also MOL #27474 15 activated by disturbing cellular adhesion to extra-cellular matrix (Sadek and Allen-Hoffmann, 1994) , increasing intracellular Ca 2+ (Reiners et al., 1990) , or disturbing cytoskeleton (Scholler et al., 1994) . The common factor between all these phenomena of ligand-independent activation of AhR is the increase in the intracellular calcium, providing the second messenger to activate AhR through the effector enzyme, calpain. Further work is required to delineate the exact mechanisms of how calpain activates AhR.
Recent studies have established that AhR, independent of PAH ligands, is directly responsible for inducing cancers of the stomach (Andersson et al., 2002) and pancreas (Koliopanos et al., 2002) and the progression of breast carcinoma (Eltom, unpublished data) . The involvement of calpain in the activation of AhR identifies calpain as a potential therapeutic target for AhR associated cancers. The advantage of this strategy is that calpain exists in a latent form requiring sustained elevation in intracellular calcium. immuno-stained for AhR followed by FITC-conjugated secondary antibodies as described in the methods.
Legends for
Cells were viewed using the IX50 Olympus Fluorescence microscope and scored for cytoplasmic and nuclear staining form multiple fields. A representative of the cellular staining for AhR is presented in 3A.
Cells were scored for cytoplasmic and nuclear staining from multiple fields from the two experiments.
Average numbers from two different experiments on the two different cell types (Hepa-1 and MT-2) were normalized to a percentage within each experiment and the average values were plotted in 3B. 
